Work

Phase I Clinical and Pharmacokinetic Study of BMS-247550, a Novel Derivative of Epothilone B, in Solid Tumors

Year: 2004

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-0919-03

Authors: Sridhar Mani, Hayley McDaid, Anne Hamilton, Howard Hochster, Marvin B. Cohen, Dineo Khabelle, Tom Griffin, David E. Lebwohl, Leonard Liebes, Franco Muggia, Susan Band Horwitz

Institutions: Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, NYU Langone Health, New York University, Bristol-Myers Squibb (United States), Yeshiva University

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, U.S. Public Health Service, National Cancer Institute

Awards: G1553362528, G16560278, Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm, PHASE I STUDIES OF ANTICANCER DRUG AND GENE THERAPY, TRANSLATIONAL CORRELATES OF AN EPOTHILONE B ANALOG, G3578179653, ANTITUMOR DRUGS--MECHANISMS OF ACTION AND RESISTANCE, G6930875742, G7194230002, G86476697

OpenAlex ID: W2109589295

FWCI: 9.023

Cites: 29

Cited by: 155

Related to: 10